Lorenzo Monti

Dr. Lorenzo Monti


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2012 in International Orthopaedics
Verified
Journal Article
Closed access
PDF file
CRCARLO ROMANO
CARLO ROMANO
OBOlivier Borens
Olivier Borens
LMLorenzo Monti
Lorenzo Monti
EMEnzo Meani
Enzo Meani
JSJose Stuyck
Jose Stuyck

16 December 2021 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
Pedro BerjanoPedro Berjano
Pedro Berjano
FLFrancesco Langella
Francesco Langella
LVLuca Ventriglia
Luca Ventriglia
DCDomenico Compagnone
Domenico Compagnone
PBPaolo Barletta
Paolo Barletta
LALaura Azzimonti
Laura Azzimonti
The study aims to create a preoperative model from baseline demographic and health-related quality of life scores (HRQOL) to predict a good to excellent early clinical outcome using a machine learning (ML) approach. A single spine surgery center retrospective review of prospectively collected data from January 2016 to December 2020 from the institutional registry (SpineREG) was performed. The inclusion criteria were age ≥ 18 years, both sexes, lumbar arthrodesis procedure, a complete follow up assessment (Oswestry Disability Index—ODI, SF-36 and COMI back) and the capability to read and understand the Italian language. A delta of improvement of the ODI higher than 12.7/100 was considered a “good early outcome”. A combined target model of ODI (Δ ≥ 12.7/100), SF-36 PCS (Δ ≥ 6/100) and COMI back (Δ ≥ 2.2/10) was considered an “excellent early outcome”. The performance of the ML models was evaluated in terms of sensitivity, i.e., True Positive Rate (TPR), specificity, i.e., True Negative Rate (TNR), accuracy and area under the receiver operating characteristic curve (AUC ROC). A total of 1243 patients were included in this study. The model for predicting ODI at 6 months’ follow up showed a good balance between sensitivity (74.3%) and specificity (79.4%), while providing a good accuracy (75.8%) with ROC AUC = 0.842. The combined target model showed a sensitivity of 74.2% and specificity of 71.8%, with an accuracy of 72.8%, and an ROC AUC = 0.808. The results of our study suggest that a machine learning approach showed high performance in predicting early good to excellent clinical results.

29 May 2022 in European Journal of Orthopaedic Surgery & Traumatology
Verified
Journal Article
Closed access
PDF file
RDRiccardo D'Ambrosi
Riccardo D'Ambrosi
NUNicola Ursino
Nicola Ursino
IMIlaria Mariani
Ilaria Mariani
KCKatia Corona
Katia Corona
FAFilippo Maria Anghilieri
Filippo Maria Anghilieri
LMLorenzo Monti
Lorenzo Monti

1 July 2022
Verified
Journal Article
Open access
LMLorenzo Monti
Lorenzo Monti
EFEmanuele Franchi
Emanuele Franchi
NUNicola Ursino
Nicola Ursino
IMIlaria Mariani
Ilaria Mariani
KCKatia Corona
Katia Corona
RDRiccardo D'Ambrosi
Riccardo D'Ambrosi
The present study aims to compare the rate of return to sports in patients who underwent surgery for mobile-bearing UKA with either hypoallergenic TiNbN or with oxidized zirconium alloy implants. The records of two consecutive cohorts for a total of 90 hypoallergenic implants were prospectively analysed. The first cohort consisted of 41 consecutive series of medial mobile-bearing hypoallergenic TiNbN UKA, whereas the second cohort consisted of 49 consecutive medial fixed-bearing hypoallergenic Uni Oxinium.The clinical evaluation involved evaluating each patient's University of California, Los Angeles (UCLA) activity scoresand the High-Activity Arthroplasty Score(HAAS). Each patient was clinically evaluated on the day before surgery (T0), then after a minimum follow-up period of 12 months (T1), and finally after 24 months (T2). Results:The only pre-operative difference between the two groups involved pre-operative BMI with significantly higher BMI in TiNbN Group (p<0.001). Both groups reported significant improvement at each follow-up compared with the previous and also at the final follow up with respect to UCLA and HAAS (p0.05). Moreover, BMI improved significantly at the final follow up, but only in TiNbN group (p<0.05). Both TiNbN and Oxinium UKA procedures enabled patients to return to an acceptable level of sports activity with excellent radiographic outcomes after the final follow up regardless of the age, gender, BMI, and bearing type.

16 December 2024 in Reumatismo
Verified
Journal Article
Open access
PDF file
LMLorenzo Monti
Lorenzo Monti
EFEmanuele Franchi
Emanuele Franchi
FVFrancesco Verde
Francesco Verde
SSStefano Sgherzi
Stefano Sgherzi
FAFilippo Maria Anghilieri
Filippo Maria Anghilieri
Objective. Intra-articular injections of hyaluronic acid (HA) have been reported to alleviate pain, reduce disability, and improve joint function in glenohumeral osteoarthritis (GH-OA). This retrospective study aimed to evaluate the effectiveness of a HA-based formulation (Hyalubrix®) in reducing the pain of patients with GH-OA and improving both patient’s shoulder functions and quality of life (QoL). Methods. Data collected during the standard clinical practice of the center was retrospectively analyzed. The Simple Shoulder Test (SST) questionnaire reported data on the patient’s ability to perform daily activities; the Euro-Quality of Life Health Assessment (EQ-5D) collected evidence on QoL; and changes in pain were evaluated through the Visual Analog Scale (VAS). SST and EQ-5D scores were analyzed comparing baseline values with those at the last follow-up, while VAS was investigated for all the available visits. Continuous values were summarized as mean ± standard deviation, median, and 25-75th percentiles. The Shapiro-Wilk test assessed normality, with significance set at p<0.05, and no adjustments for multiple comparisons were made. Results. All scores showed a significant improvement: VAS decreased from 55.4±13.8 to 16.2±16.3 (p<0.001), the SST increased from 38.0 to 65.5 (p<0.001), as did the EQ-5D (from 41.7 to 76.7; p<0.001). Conclusions. GH-OA treatment with Hyalubrix® proved to be highly beneficial, leading to complete pain reduction in more than 50% of patients and a significant reduction in 27.5% of cases. This resulted in improved joint function and QoL.

1 December 2013 in Aggiornamenti CIO
Verified
Journal Article
Closed access
PDF file
LMLorenzo Monti
Lorenzo Monti
GDG. Pedrotti Dell’acqua
G. Pedrotti Dell’acqua
RAR. Accetta
R. Accetta